FAQs about delivery changes

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

52.41 -0.09 (-0.18%)
Streaming Delayed Price Updated: 12:01 PM EDT, Jun 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
45 46 Next >
News headline image
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant ↗
Read the latest report on NanoViricides here 
Via Benzinga
News headline image
7 ‘Smart Money’ Stocks Set to Explode Higher ↗
Invest like the pros by wagering on these top seven smart money stocks to buy at this time, offering tremendous upside ahead. 
Via InvestorPlace
News headline image
Moderna's Shares Could Take Off if These 2 Things Happen ↗
Moderna stock soared early in the pandemic. 
Via The Motley Fool
News headline image
Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs ↗
U.S. President Joe Biden is set to unveil a $100 million research initiative to tackle the growing threat of drug-resistant bacteria.  More than a million people worldwide succumb to infections caused... 
Via Benzinga
News headline image
Price Over Earnings Overview: GSK ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About GSK? ↗
 
Via Benzinga
News headline image
Peering Into GSK's Recent Short Interest ↗
 
Via Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
By David Willey, Benzinga 
Via TheNewswire.com
News headline image
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant ↗
Read the latest report on NanoViricides here 
Via Benzinga
News headline image
Why Are Antifungal Focused Scynexis Stock Plunging Today? ↗
Scynexis Inc (NASDAQ: SCYX) is voluntarily recalling its antifunga 
Via Benzinga
News headline image
CDC Backs Pfizer's RSV Infection Maternal Vaccine During Pregnancy As Protection For Infants ↗
Friday, The Centers for Disease Control and Prevention recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborns from severe RSV 
Via Benzinga
News headline image
Amazon Poaches Microsoft's Product Chief, Google And DoD Team Up For AI-Powered Microscope To Identify Cancer, Rocket Lab's 41st Mission Succumbed To Technical Issues: Today's Top Stories ↗
Bloomberg 
Via Benzinga
News headline image
European Commission Approves GSK/Pfizer-Backed HIV Infection Prevention Drug ↗
The European Commission has approved ViiV Healthcare's Apretude (cabotegravir long-acting (LA) injectable and tablets)  
Via Benzinga
News headline image
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison ↗
Friday, the FDA approved GSK plc's (NYSE: GSK) Ojjaara (momelotinib) for intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythemia vera and... 
Via Benzinga
News headline image
Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival ↗
Both companies now sell treatments for myelofibrosis, a rare bone marrow cancer. 
Via Investor's Business Daily
News headline image
One Year Into Kabir Nath's Leadership, Compass Pathways' (NASDAQ: CMPS) Phase 3 Trial For Innovative Treatment Resistant Depression Progressing ↗
Treatment-resistant depression, also referred to as TRD, is a subset of depression that poses significant challenges for clinicians, patients and those closest to patients. It is characterized by... 
Via Benzinga
News headline image
Pleasant Surprise For GSK: FDA Approves Bone Marrow Cancer Therapy Acquired Via Sierra Oncology Deal ↗
FDA has  
Via Benzinga
News headline image
Ojjaara (momelotinib) approved in the US as the first and only treatment indicated for myelofibrosis patients with anemia
From GSK plc
Via Business Wire
News headline image
Moderna's R&D Day Unveils Strategic Roadmap Beyond COVID Franchise: Goldman Sachs ↗
On Wednesday, Moderna Inc (NASDAQ: MRNA) conducted an R&D Day event outlining its strategic initiatives across four key areas - Respiratory Vaccines, Latent/Other Vaccines, Oncology Therapeutics,  
Via Benzinga
News headline image
Flu Vaccine Results Give Moderna (MRNA) Stock a Shot in the Arm ↗
Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony. 
Via InvestorPlace
News headline image
Moderna Stock Has Been Beaten Up; Why The CFO Says Its Story Is 'Misunderstood' ↗
Moderna unveiled promising results in flu on Wednesday, adding to its respiratory suite. 
Via Investor's Business Daily
News headline image
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch ↗
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
News headline image
3 Pharmaceutical Stocks That Are Too Cheap to Ignore ↗
Viatris, GSK, and Organon are all trading at less than 7 times earnings. 
Via The Motley Fool
News headline image
GSK and Earvin “Magic” Johnson to Host Community Awareness Events about Older Adult Risk for RSV at YMCA Locations
From GSK plc
Via Business Wire
News headline image
Vivek Ramaswamy's Parallels With Warren Buffett Run Deeper Than Wanting To Make Roivant The 'Berkshire Hathaway Of Drug Development' ↗
Presidential hopeful Vivek Ramaswamy and Warren Buffett may share different political ideologies but they have at least a couple of things in common. 
Via Benzinga
News headline image
7 Stocks Hedge Funds Are Loading Up On ↗
Hedge funds and many other financial institutions are loading up on these names considered to be among top institutional stock picks. 
Via InvestorPlace
News headline image
GSK To Invest $272M In New Vaccine Facility Near Brussels, Slated To Open In 2027 ↗
GSK Plc (NYSE: GSK) has made an investment of over €250 million ($272 million) in a vaccine facility located in Belgium. 
Via Benzinga
News headline image
3 Growth Stocks to Ride the Coming Bull Market in Style ↗
Bull markets always follow bear markets, and these three companies are growth stocks to buy for the next wave higher 
Via InvestorPlace
News headline image
3 Sorry Pharma Stocks to Sell in August Before It’s Too Late ↗
Factors in the marketplace caused these companies to underperform, making them some of the top pharma stocks to sell. 
Via InvestorPlace
News headline image
FDA Greenlights Pfizer's RSV Vaccine: Moms Can Now Protect Babies Before Birth ↗
Monday, the FDA approved Pfizer Inc's (NYSE: PFE) Abrysvo (Respiratory Syncytial Virus Vaccine), the company's bivalent RSV prefusion F (RSVpreF) vaccine, to prevent the infection in infants from birth... 
Via Benzinga
< Previous 1 2
...
16 17 18 19 20 21 22 23 24
...
45 46 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article